Search Results - "Koelfat, K"
-
1
The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapy
Published in Journal of inherited metabolic disease (01-03-2019)“…Introduction Currently, no therapies are available for Zellweger spectrum disorders (ZSDs), a group of genetic metabolic disorders characterised by a…”
Get full text
Journal Article -
2
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge
Published in Hepatology international (01-01-2017)“…Background Bile salts likely contribute to liver injury in patients with primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC). Fibroblast…”
Get full text
Journal Article -
3
Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure
Published in Hepatology (Baltimore, Md.) (01-11-2021)“…Background and Aims Automated chyme reinfusion (CR) in patients with intestinal failure (IF) and a temporary double enterostomy (TDE) restores intestinal…”
Get full text
Journal Article -
4
Cholic acid therapy in Zellweger spectrum disorders
Published in Journal of inherited metabolic disease (01-11-2016)“…Introduction Zellweger spectrum disorders (ZSDs) are characterized by a failure in peroxisome formation, caused by autosomal recessive mutations in different…”
Get full text
Journal Article -
5
Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients
Published in Hepatology (Baltimore, Md.) (01-07-2019)“…Critical illness is associated with a disturbed regulation of gastrointestinal hormones resulting in functional and metabolic anomalies. Fibroblast growth…”
Get full text
Journal Article -
6
-
7
FRI-223 - Elevated plasma levels of FGF19 isassociated with repression of bile salt synthesis in patients with obstructivecholestasis
Published in Journal of hepatology (01-04-2018)Get full text
Journal Article -
8
Elevated plasma levels of FGF19 isassociated with repression of bile salt synthesis in patients with obstructivecholestasis
Published in Journal of hepatology (01-04-2018)Get full text
Journal Article -
9
The portal‐drained viscera release fibroblast growth factor 19 in humans
Published in Physiological reports (01-12-2016)“…Fibroblast growth factor 19 (FGF19) is an ileum‐derived endrocrine factor that is produced in response to transepithelial bile salt flux. FGF19 represses bile…”
Get full text
Journal Article -
10
-
11
-
12
Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score)
Published in The American journal of clinical nutrition (01-06-2019)“…Patients with chronic intestinal failure (CIF) often develop cholestatic liver injury, which may lead to liver failure and need for organ transplantation. The…”
Get full text
Journal Article -
13
OR55: Disturbed Enterohepatic Bile Salt Signaling in Intensive Care Patients with Diarrhea
Published in Clinical nutrition (Edinburgh, Scotland) (01-09-2017)Get full text
Journal Article -
14
Microbially conjugated bile salts found in human bile activate the bile salt receptors TGR5 and FXR
Published in Hepatology communications (01-04-2024)“…Bile salts of hepatic and microbial origin mediate interorgan cross talk in the gut-liver axis. Here, we assessed whether the newly discovered class of…”
Get full text
Journal Article -
15
Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease
Published in Clinical nutrition (Edinburgh, Scotland) (01-10-2017)“…Summary Background & aims Parenteral nutrition (PN), a lifesaving therapy in patients with intestinal failure, has been associated with hepatobiliary…”
Get full text
Journal Article -
16
Partial liver resection alters the bile salt-FGF19 axis in patients with perihilar cholangiocarcinoma: Implications for liver regeneration
Published in Hepatology communications (01-06-2024)“…Extended liver resection is the only treatment option for perihilar cholangiocarcinoma (pCCA). Bile salts and the gut hormone FGF19, both promoters of liver…”
Get full text
Journal Article -
17
The cholic acid extension study in Zellweger spectrum disorders: results and implications for therapy
Published in Journal of inherited metabolic disease (15-05-2018)“…Currently, no therapies are available for Zellweger spectrum disorders (ZSDs), a group of genetic metabolic disorders characterised by a deficiency of…”
Get full text
Journal Article -
18
Bile Salt and FGF19 Signaling in the Early Phase of Human Liver Regeneration
Published in Hepatology communications (01-08-2021)“…The involvement of bile salt–fibroblast growth factor 19 (FGF19) signaling in human liver regeneration (LR) is not well studied. Therefore, we studied aspects…”
Get full text
Journal Article -
19
La réinstillation du chyme restaure la signalisation de la sécrétion des sels biliaires (étude RESCUE)
Published in Nutrition clinique et métabolisme (01-04-2020)“…Une entérostomie double temporaire (ESDT) peut entraîner une insuffisance intestinale de type II (II2) et interrompre le cycle entéro-hépatique (CEH) des sels…”
Get full text
Journal Article -
20
Chyme reinfusion restores the regulatory bile salt-FGF19 axis in intestinal failure patients
Published in Hepatology (Baltimore, Md.) (16-06-2021)“…Background and aims - Automated chyme reinfusion (CR) in patients with intestinal failure (IF) and a temporary double enterostomy (TDE) restores intestinal…”
Get full text
Journal Article